Requirements for mutant and wild-type prion protein misfolding in vitro

Geoffrey P Noble1, Daniel J Walsh, Michael B Miller

  • 1Department of Biochemistry, The Geisel School of Medicine at Dartmouth , Vail Building Room 311, Hanover, New Hampshire 03755, United States.

Biochemistry
|January 14, 2015
PubMed

Insights

Pathogenic prion protein (PrP) mutants misfold spontaneously, templating abnormal conformations. Wild-type PrP inhibits this process, suggesting cellular factor involvement in inherited prion diseases.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Molecular Biology

Background:

  • Prion protein (PrP) misfolding is central to prion disease pathogenesis.
  • Understanding PrP misfolding mechanisms is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the in vitro misfolding of the pathogenic PrP mutant D177N using a chemically defined system.
  • To elucidate the factors influencing spontaneous PrP misfolding and templating.

Main Methods:

  • Utilized a chemically defined prion propagation system.
  • Studied the D177N PrP mutant's spontaneous misfolding kinetics.
  • Assessed the templating ability of misfolded mutant PrP onto wild-type PrP.
  • Investigated the role of phospholipids and cofactor molecules.

Main Results:

  • The D177N PrP mutant misfolded spontaneously, influenced by time, temperature, pH, and sonication.
  • Spontaneously misfolded mutant PrP templated its conformation onto wild-type PrP via a distinct phospholipid activity.
  • Pathogenic mutant E199K showed similar behavior, while M128V did not.
  • Wild-type PrP inhibited mutant PrP misfolding, an effect antagonized by cofactors.

Conclusions:

  • PrP misfolding in inherited prion diseases is controlled by interactions between mutant PrP, wild-type PrP, and cellular factors.
  • Distinct mechanisms govern spontaneous mutant PrP misfolding and templating compared to infectious prion propagation.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
21.1K
Protein Folding01:22

Protein Folding

Overview
131.4K
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
12.8K